<DOC>
	<DOCNO>NCT00367731</DOCNO>
	<brief_summary>After Initiation HAART people live HIV/AIDS Thailand year 2000 , rapidly expand HAART access national project promote 2004 . Free ARVs ( For CD4 &lt; 200cell/cu.mm . symptomatic HIV CD4 &lt; 250 cell/cu.mm . ) CD4 monitoring available . The first-line regimen d4T+3TC+NVP mainly first time ( Naive ) patient . CD4 response ) , rate opportunistic infection , neurological outcome measure . Rate ARV change , adverse event , treatment failure , TB co-infection rate , percent change EFV-based regimen PI-based regimen record . Any Adverse Events include , Sever rash , Severe Hepatitis , Lipid abnormality , Severe Anemia Other , common AEs analyse .</brief_summary>
	<brief_title>NOW Thai HAART Study</brief_title>
	<detailed_description />
	<criteria>HIV/AIDS patient . Age &gt; 15 year . inform consent Not inform consent</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>Neurological complication</keyword>
	<keyword>HAART</keyword>
</DOC>